BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36010908)

  • 1. Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast.
    Badve SS; Cho S; Lu X; Cao S; Ghose S; Thike AA; Tan PH; Ocal IT; Generali D; Zanconati F; Harris AL; Ginty F; Gökmen-Polar Y
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocytes in ductal carcinoma in situ (DCIS)-assessment with three different methodologies and correlation with Oncotype DX DCIS Score.
    Komforti M; Badve SS; Harmon B; Lo Y; Fineberg S
    Histopathology; 2020 Nov; 77(5):749-759. PubMed ID: 32557780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast.
    Toss MS; Miligy I; Al-Kawaz A; Alsleem M; Khout H; Rida PC; Aneja R; Green AR; Ellis IO; Rakha EA
    Mod Pathol; 2018 Aug; 31(8):1226-1236. PubMed ID: 29559742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
    Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N
    BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Touching tumour-infiltrating lymphocytes in low-risk ductal carcinoma in situ (DCIS) correlate with upgrading to high-grade DCIS.
    Khoury T; Quinn M; Tian W; Yan L; Zhan H
    Histopathology; 2022 Jan; 80(2):291-303. PubMed ID: 34379814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.
    Schiza A; Thurfjell V; Stenmark Tullberg A; Olofsson H; Lindberg A; Holmberg E; Bremer T; Micke P; Karlsson P; Wärnberg F; Strell C
    Eur J Cancer; 2022 Jun; 168():128-137. PubMed ID: 35236568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ.
    Xu FF; Zheng SF; Xu C; Cai G; Wang SB; Qi WX; Wang CF; Chen JY; Lu C
    Oncoimmunology; 2021 Mar; 10(1):1875637. PubMed ID: 33796401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
    Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
    Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis.
    Wu SL; Yu X; Mao X; Jin F
    BMC Cancer; 2022 Jul; 22(1):782. PubMed ID: 35843951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.
    Pruneri G; Lazzeroni M; Bagnardi V; Tiburzio GB; Rotmensz N; DeCensi A; Guerrieri-Gonzaga A; Vingiani A; Curigliano G; Zurrida S; Bassi F; Salgado R; Van den Eynden G; Loi S; Denkert C; Bonanni B; Viale G
    Ann Oncol; 2017 Feb; 28(2):321-328. PubMed ID: 28426105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
    Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA
    Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast.
    Jia H; Zhao P; Chen Z; Wang G; Dong X; Xing X; Tan X; Wang C
    Breast Cancer Res Treat; 2022 May; 193(1):111-120. PubMed ID: 35260954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher densities of tumour-infiltrating lymphocytes and CD4
    Thike AA; Chen X; Koh VCY; Binte Md Nasir ND; Yeong JPS; Bay BH; Tan PH
    Histopathology; 2020 May; 76(6):852-864. PubMed ID: 31883279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma
    Farolfi A; Petracci E; Serra L; Ravaioli A; Bravaccini S; Ravaioli S; Tumedei MM; Ulivi P; Canale M; Puccetti M; Falcini F; Folli S; Curcio A; Rocca A
    Front Oncol; 2020; 10():1486. PubMed ID: 32974178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.
    Polónia A; Pinto R; Cameselle-Teijeiro JF; Schmitt FC; Paredes J
    J Clin Pathol; 2017 Oct; 70(10):860-867. PubMed ID: 28373294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.
    Droeser R; Zlobec I; Kilic E; Güth U; Heberer M; Spagnoli G; Oertli D; Tapia C
    BMC Cancer; 2012 Apr; 12():134. PubMed ID: 22471961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
    Hwang C; Lee SJ; Lee JH; Kim KH; Suh DS; Kwon BS; Choi KU
    Oncol Lett; 2019 May; 17(5):4557-4565. PubMed ID: 30944645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible predictive role of cancer/testis antigens in breast ductal carcinoma
    Roguljic A; Spagnoli G; Juretic A; Sarcevic B; Banovic M; Beketic Oreskovic L
    Oncol Lett; 2018 Dec; 16(6):7245-7255. PubMed ID: 30546463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of the Breast Ductal Carcinoma
    Hendry S; Pang JB; Byrne DJ; Lakhani SR; Cummings MC; Campbell IG; Mann GB; Gorringe KL; Fox SB
    Clin Cancer Res; 2017 Sep; 23(17):5210-5217. PubMed ID: 28611201
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.